首页> 外文期刊>Future Journal of Pharmaceutical Sciences >Application of Box-Behnken design and desirability function in the development and optimization of self-nanoemulsifying drug delivery system for enhanced dissolution of ezetimibe
【24h】

Application of Box-Behnken design and desirability function in the development and optimization of self-nanoemulsifying drug delivery system for enhanced dissolution of ezetimibe

机译:Box-Behnken设计和可取性功能在自纳乳化药物输送系统开发和优化中的应用,以增强Ezetimibe解

获取原文
           

摘要

Background:This study is focused on developing and optimizing a self-nanoemulsifying drug delivery system (SNEDDS) of BCS class II drug (ezetimibe) through Box–Behnken design (BBD) and desirability function for enhanced dissolution.Pseudoternary phase diagrams were created by taking oil (Peceol), surfactant (Tween80), and co-surfactant (Transcutol-P) and the concentration ranges were identified for generating BBD. The composition of ezetimibe-SNEDDS was optimized through various response variables viz. globule size (Y1), %transmittance (Y2), self-emulsification time (Y3), dissolution after 5 min and 40 min (Y4, Y5). Optimized formulation was characterized for various physicochemical properties.ResultsPseudoternary phase diagram having maximum nano-emulsification area was selected to formulate SNEDDS. Derived polynomial equation and model graphs were exercised to investigate the impact of formulation variables on the responses. Significant effect of formulation composition on the responses was observed (p < 0.05). The formulation with least oil (10%) and high surfactant (60%) exhibited low globule size (24.4 ± 2.07?nm), low emulsification time (55 s) but high %transmittance (101.2%) and drug release (49.21% after 5 min; 95.27% after 40 min). Based on the desirability function, the optimized formulation was selected and reformulated. The optimized formulation (FF1) was found to be uniform, stable, and showed similar observed and predicted responses.ConclusionThe potential of SNEDDS in improving the dissolution profile of weakly soluble drug and the applicability of BBD with desirability function in optimizing a SNEDD formulation has made it possible to identify the impact of various independent variables on optimization of the formulation for better responses.
机译:背景:本研究专注于通过Box-Behnken设计(BBD)的BCS II类药物(Ezetimibe)的自我纳米乳化药物输送系统(SNEDDS)的开发和优化,并获得增强溶解的可取性功能。通过服用创建了份额相阶段图鉴定出油(磷酸),表面活性剂(Tween80)和共表面活性剂(Transcutol-P)和浓度范围用于产生BBD。通过各种响应变量viz优化ezetimibe-snedds的组成。球尺寸( y 1 ),%透射率( y 2 ),自乳化时间( Y 3 ),5分钟后溶解,40分钟( Y 4 , Y 5 )。优化的制剂的特征在于各种物理化学性质。选择具有最大纳米乳化区域的培制型相图以配制鼻涕。衍生的多项式方程和模型图进行了旨在调查配方变量对响应的影响。观察到配方组合物对应答的显着效果( P <0.05)。具有最少油(10%)和高表面活性剂(60%)的配方表现出低球尺寸(24.4±2.07μm),低乳化时间(55秒),但透射率高(101.2%)和药物释放(49.21%) 5分钟; 40分钟后95.27%)。基于期望功能,选择并重新制定优化的制剂。发现优化的制剂(FF1)是均匀的,稳定的,并且显示出类似的观察和预测的反应。结论SNEDDS在改善弱可溶性药物的溶出曲线方面的潜力以及BBD在优化SNEDD配方中的应用功能的应用可以识别各种独立变量对制剂的优化的影响,以获得更好的反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号